Urology Market Size, Share & Trends Analysis | Japan | 2020-2026 | MedSuite | Includes: Urinary Incontinence Market, Pelvic Organ Prolapse Repair Market, and 3 more
- Year: 2020
- Scope: 10 Years
- Region: Japan
- Pages: 369
- Published Date: 11/08/2019
- Type: MedSuite
In 2020, the urological device market size in Japan was valued at $383 million, with over 540,000 urological procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.3% to reach $480 million in 2026.
Throughout this medical market research, we analyzed 31 urology companies across Japan and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
While this MedSuite report contains all of the Japanese Urological Device market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Urology Procedure Volumes
- Market Forecasts Until 2026, and Historical Data to 2016
- Competitive Analysis with Market Shares for Each Segment
- Market Drivers & Limiters for Each Urological Device market
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Market Value and Industry Trends
The stone management device market, BPH treatment market and urinary incontinence management device market accounted for the vast majority of the total market in 2019. The growth in these segments is driven by the stable demand for related procedures and the increasing prevalence of prostatic and kidney diseases, fueled by the aging population of Japan. The rapidly growing aging population of the region is forcing structural changes in the market, due to the increasing prevalence of chronic and age-related diseases.
The female urinary incontinence sling market is undergoing structural changes, due to global regulatory changes regarding transvaginal tape and mini-slings. In April 2019, the U.S. Food and Drug Administration (FDA) ordered all manufacturers of surgical mesh intended for transvaginal repair of anterior compartment prolapse (cystocele) to stop selling and distributing their products immediately. This resulted in a significant decline of the urinary incontinence sling market in Japan.
By 2020, the leading competitors in the urological device market included Lumenis, Boston Scientific, and BARD, collectively representing around half of the total market value. The Japanese market is highly fragmented.
Boston Scientific’s position is secured by the company’s presence in every segment of the urological market. Lumenis is focused on laser equipment, lithotripters, and other capital equipment for stone management and BPH treatment, which were the second-largest portions of the total market. BARD dominated the urinary catheter segment, which generated the overwhelming majority of the urinary incontinence management market.
A large portion of the total market was shared by competitors with less than 10% of the total market share each. The combined urological device market is primarily defined by competitors in the stone management treatment and BPH treatment market, resulting in a strong focus on disposables and capital equipment.
Click on each title to view detailed market segmentation.
- Procedure Volumes for Urological Devices – MedPro – The complete procedural analysis of the urological device market in Japan, which includes Incontinence Sling Implantation, Artificial Urinary Sphincter Implantation, Transvaginal Tape Incontinence Sling, Transobturator Incontinence Sling, Extracorporeal Shockwave Lithotripsy, Percutaneous Nephrolithotomy procedures, and multiple others for each of the analyzed market segments.
- Urinary Incontinence Market – MedCore – This market is further segmented into market segments, such as Urinary Catheters, Urethral Bulking Agents, and Incontinence Management device markets.
- Pelvic Organ Prolapse Repair Market – MedCore – The market is comprised of the segments for Transvaginal and Sacrocolpopexy Meshes.
- Stone Management Market – MedCore – This market is categorized by Device Type into ESWL Equipment, ISWL Equipment, Holmium Lasers, Stone Fragment Retrieval Device, Ureteral Stent, and Ureteral Guidewire market segments.
- Benign Prostatic Hyperplasia (BPH) Treatment Market – MedCore – This market is segmented by Device Type, including Transurethral Resection of Prostate, Laser BPH, UroLift, and Rezūm device market segments.
- Erectile Dysfunction Market – MedCore – The market is comprised of the segments for Inflatable, Malleable, and Vacuum devices.
Detailed Market Segmentation
DON’T SEE THE SEGMENT OR DATA YOU NEED?
Feel free to contact us or send a request by pressing one of the buttons below.
TABLE OF CONTENTS for The JAPAN UROLOGY MARKET Report SuiteTABLE OF CONTENTS ILIST OF FIGURES XLIST OF CHARTS XIXEXECUTIVE SUMMARY 1JAPAN UROLOGICAL DEVICES MARKET OVERVIEW 1COMPETITIVE ANALYSIS 3MARKET TRENDS 5MARKET DEVELOPMENTS 6PROCEDURE NUMBERS 8MARKETS INCLUDED 9KEY REPORT UPDATES 11VERSION HISTORY 11RESEARCH METHODOLOGY 12Step 1: Project Initiation & Team Selection 12Step 2: Prepare Data Systems and Perform Secondary Research 15Step 3: Preparation for Interviews & Questionnaire Design 17Step 4: Performing Primary Research 18Step 5: Research Analysis: Establishing Baseline Estimates 20Step 6: Market Forecast and Analysis 21Step 7: Identify Strategic Opportunities 23Step 8: Final Review and Market Release 24Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW2.1 BASIC ANATOMY 262.1.1 Urinary System 222.214.171.124 Male Urinary System 2126.96.36.199 Female Urinary System 282.2 DISEASE TREATMENT AND DIAGNOSTICS 292.2.1 Benign Prostatic Hyperplasia 292.2.2 Urinary Incontinence 312.2.3 Urinary Tract Infections 332.2.4 Kidney Stones 342.2.5 Bladder Prolapse 362.2.6 Overactive Bladder 372.2.7 Prostatitis 382.2.8 Erectile Dysfunction 402.2.9 Cancer 4188.8.131.52 Prostate Cancer 4184.108.40.206 Bladder Cancer 432.2.10 Indications for Pelvic Organ Prolapse Repair 45 PRODUCT ASSESSMENT 3.1 INTRODUCTION 463.2 PRODUCT PORTFOLIOS 463.2.1 Urinary Incontinence 4220.127.116.11 Urinary Catheters 418.104.22.168.1 Intermittent Catheters 422.214.171.124.2 Foley Catheters 4126.96.36.199.3 Male External Catheters 4188.8.131.52 Urethral Bulking Agents 4184.108.40.206 Incontinence Management Devices 503.2.1.3.1 Female Incontinence Slings 503.2.1.3.2 Male Implantable Devices 5220.127.116.11 Urine Bags 518.104.22.168.1 Leg Bags 522.214.171.124.2 Night Bags 533.2.2 Pelvic Organ Prolapse Repair 5126.96.36.199 Autologous tissue as an alternative to vaginal mesh 5188.8.131.52 Product Matrix for Pelvic Organ Prolapse Repair 603.2.3 Stone Management 6184.108.40.206 ESWL Equipment 6220.127.116.11 ISWL Equipment 618.104.22.168 Holmium Lasers 622.214.171.124 Stone Fragment Retrieval Devices 6126.96.36.199 Ureteral Stents 633.2.4 BPH Treatment 6188.8.131.52 TURP 6184.108.40.206 TUMT 6220.127.116.11 TUNA 618.104.22.168 Prostatic Stents 622.214.171.124 Laser BPH 703.2.4.5.1 Photoselective Vaporization of the Prostate (PVP) 7126.96.36.199.2 Laser Vaporization of the Prostate 7188.8.131.52.3 Laser Ablation of the Prostate 7184.108.40.206.4 Laser Resection of the Prostate 7220.127.116.11.5 Laser Enucleation of the Prostate 743.2.5 Erectile Dysfunction 718.104.22.168 Penile Implants 722.214.171.124.1 Inflatable 7126.96.36.199.2 Malleable 7188.8.131.52 Vacuum 773.3 REGULATORY ISSUES AND RECALLS 793.3.1 Boston Scientific 7184.108.40.206 Stone Management 7220.127.116.11 Nephrostomy 813.3.2 C. R. Bard (Becton Dickinson) 818.104.22.168 Urinary Incontinence 822.214.171.124 Stone Management 8126.96.36.199 Urological Endoscopes 8188.8.131.52 Prostate Cancer Treatment 8184.108.40.206 Nephrostomy 883.3.3 Coloplast 903.3.3.1 Urinary Catheter 903.3.3.2 Erectile Dysfunction 903.3.4 Cook Medical 9220.127.116.11 Stone Management 918.104.22.168 Nephrostomy 923.3.5 Elekta 922.214.171.124 Prostate Cancer Treatment 943.3.6 Karl Storz 9126.96.36.199 Urological Endoscopes 953.3.7 Olympus 9188.8.131.52 Urological Endoscopes 963.4 CLINICAL TRIALS 983.4.1 Boston Scientific 9184.108.40.206 Urinary Incontinence 9220.127.116.11 BPH Treatment 918.104.22.168 Urological endoscopes 1003.4.1.4 Nephrostomy 1013.4.1.5 Erectile Dysfunction 1023.4.2 C. R. Bard (Becton Dickinson) 1033.4.2.1 Urinary Incontinence 1033.4.2.2 Prostate Cancer Treatment 1053.4.3 Coloplast 1063.4.3.1 Urinary Incontinence 1063.4.4 Cook Medical 1093.4.4.1 Nephrostomy 1093.4.5 Elekta 122.214.171.124 Prostate Cancer Treatment 1113.4.6 Ethicon 1126.96.36.199 Urinary Incontinence 1133.4.7 Karl Storz 1188.8.131.52 Stone Management 1184.108.40.206 Urological Endoscopes 1173.4.8 LABORIE 1220.127.116.11 Urodynamics 1203.4.9 Medline 118.104.22.168 Urinary Incontinence 1223.4.10 Olympus 122.214.171.124 Stone Management 1126.96.36.199 BPH Treatment 1243.4.10.3 Urological Endoscopes 125
JAPAN UROLOGICAL DEVICE MARKET OVERVIEW4.1 INTRODUCTION 1274.2 CURRENCY EXCHANGE RATE 1294.3 MARKET OVERVIEW 1304.4 TREND ANALYSIS BY SEGMENT 1364.5 DRIVERS AND LIMITERS 1394.5.1 Market Drivers 1394.5.2 Market Limiters 1404.6 COMPETITIVE MARKET SHARE ANALYSIS 1434.7 MERGERS AND ACQUISITIONS 1504.8 COMPANY PROFILES 1524.8.1 Boston Scientific 1524.8.2 C. R. Bard (Becton Dickinson) 1544.8.3 Coloplast 1564.8.4 Cook Medical 1574.8.5 Ethicon (Johnson & Johnson) 1584.8.6 Karl Storz 1594.8.7 LABORIE 1604.8.8 Olympus 1614.9 SWOT ANALYSIS 1634.9.1 Boston Scientific 1644.9.2 C. R. Bard (Becton Dickinson) 1664.9.3 Coloplast 1684.9.4 Cook Medical 1694.9.5 Ethicon (Johnson & Johnson) 1714.9.6 Karl Storz 1724.9.7 LABORIE 1734.9.8 Olympus 174 PROCEDURE NUMBERS 5.1 PROCEDURE OVERVIEW 1765.2 URINARY INCONTINENCE PROCEDURES 1815.2.1 Male Incontinence Management Procedures 1835.2.2 Female Incontinence Management Procedures 1855.3 PELVIC ORGAN PROLAPSE REPAIR 1885.4 STONE MANAGEMENT PROCEDURES 1905.4.1 ESWL Procedures 1935.4.2 Transurethral Procedures 1955.4.3 Ureteral Stent Placement Procedures 1975.4.4 PCNL Procedures 1995.5 BPH PROCEDURES 2015.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 204
URINARY INCONTINENCE MANAGEMENT DEVICE MARKET6.1 INTRODUCTION 2076.2 MARKET OVERVIEW 2096.3 MARKET ANALYSIS AND FORECAST 2146.3.1 Total Urinary Catheter Market 2188.8.131.52 Intermittent Catheter Market 2184.108.40.206 Foley Catheter Market 2220.127.116.11 Male External Catheter Market 2216.3.2 Urethral Bulking Agent 2236.3.3 Total Incontinence Management Device Market 2246.3.3.1 Total Female Incontinence Sling Market 2218.104.22.168.1 Transvaginal Tape Female Incontinence Sling Market 2322.214.171.124.2 Transobturator Female Incontinence Sling Market 23126.96.36.199 Total Male Implantable Incontinence Device Market 23188.8.131.52.1 Male Incontinence Sling Market 24184.108.40.206.2 Male Artificial Urinary Sphincter Market 2436.4 DRIVERS AND LIMITERS 2456.4.1 Market Drivers 2456.4.2 Market Limiters 2456.5 COMPETITIVE MARKET SHARE ANALYSIS 248 PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET 7.1 INTRODUCTION 2537.2 MARKET OVERVIEW 2557.3 MARKET ANALYSIS AND FORECAST 2607.3.1 Total Pelvic Organ Prolapse Repair Device Market 2607.3.2 Transvaginal Mesh Market 2637.3.3 Sacrocolpopexy Mesh Market 2657.4 DRIVERS AND LIMITERS 2677.4.1 Market Drivers 2677.4.2 Market Limiters 2677.5 COMPETITIVE MARKET SHARE ANALYSIS 269
STONE MANAGEMENT DEVICE MARKET>8.1 INTRODUCTION 2728.2 MARKET OVERVIEW 2758.3 MARKET ANALYSIS AND FORECAST 2818.3.1 ESWL Equipment Market 2818.3.2 ISWL Equipment Market 2848.3.3 Total Holmium Laser Market 28220.127.116.11 Holmium Laser Equipment Market 2818.104.22.168 Holmium Laser Fiber Market 2918.3.4 Total Stone Fragment Retrieval Device Market 2922.214.171.124 Nitinol Stone Fragment Retrieval Device Market 29126.96.36.199 Stainless Steel Stone Fragment Retrieval Device Market 3018.3.5 Ureteral Stent Market 3038.3.6 Ureteral Guidewire Market 3058.4 DRIVERS AND LIMITERS 3078.4.1 Market Drivers 3078.4.2 Market Limiters 3088.5 COMPETITIVE MARKET SHARE ANALYSIS 310
BPH TREATMENT DEVICE MARKET9.1 INTRODUCTION 3169.1.1 Treatments 3179.1.2 Comparison of TURP and Laser BPH Procedures 3189.1.3 Emerging Technologies 3189.2 MARKET OVERVIEW 3209.3 MARKET ANALYSIS AND FORECAST 3259.3.1 Total TURP Market 32188.8.131.52 Monopolar Electrode Market 32184.108.40.206 Bipolar Electrode Market 3309.3.2 Total Laser BPH Market 33220.127.116.11 Laser BPH Equipment Market 3318.104.22.168 Laser BPH Fiber Market 3379.3.3 UroLift® Market 3399.3.4 Rezum® Market 3429.4 DRIVERS AND LIMITERS 3439.4.1 Market Limiters 3449.5 COMPETITIVE MARKET SHARE ANALYSIS 347
ERECTILE DYSFUNCTION DEVICE MARKET10.1 INTRODUCTION 35110.1.1 Low Testosterone Pharmaceutical Delivery 35210.2 MARKET OVERVIEW 35310.3 MARKET ANALYSIS AND FORECAST 35810.3.1 Inflatable Erectile Dysfunction Device Market 35810.3.2 Malleable Erectile Dysfunction Device Market 36010.3.3 Vacuum Erectile Dysfunction Device 36210.4 DRIVERS AND LIMITERS 36310.4.1 Market Drivers 36310.4.2 Market Limiters 36310.5 COMPETITIVE MARKET SHARE ANALYSIS 365
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.